Sook-Kwan Leang

Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release.

Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses.

Influenza antiviral resistance in the Asia-Pacific region during 2011.

Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient.

Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses.

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.

Affective dysfunction in a mouse model of Rett syndrome: Therapeutic effects of environmental stimulation and physical activity.

Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.